Cardiac allograft vasculopathy optical coherence tomography

Jump to navigation Jump to search

Cardiac allograft vasculopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Cardiac allograft vasculopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Coronary Angiography

Intravascular Ultrasound

Optical Coherence Tomography

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac allograft vasculopathy optical coherence tomography On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac allograft vasculopathy optical coherence tomography

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac allograft vasculopathy optical coherence tomography

CDC on Cardiac allograft vasculopathy optical coherence tomography

Cardiac allograft vasculopathy optical coherence tomography in the news

Blogs on Cardiac allograft vasculopathy optical coherence tomography

Directions to Hospitals Treating Cardiac allograft vasculopathy

Risk calculators and risk factors for Cardiac allograft vasculopathy optical coherence tomography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

In 2010, U.S FDA approved coronary optical cohorence tomography (OCT) as a new catheter based intra-vascular imaging modality with a resolution higher than intravascular ultrasound (IVUS). OCT uses near infra-red light and constructs images from the reflected light which is in the same phase (i.e cohorent) with the emitted light. This eliminated the interference from scattered light, thereby producing images with higher resolution.

Coronary Optical Cohorence Tomography

Advantages

  • Allows rapid imaging of coronaries with a higher radial resolution.
  • Detects more subtle changes in the intima-media thickness compared to IVUS in patients with early CAV.
  • Accurate plaque characterization[1].

Limitations

  • Complete blood washout from the coronaries is necessary to obtain good quality images.
  • Deep tissue penetration is not as good as IVUS[1].

References

  1. 1.0 1.1 Khandhar SJ, Yamamoto H, Teuteberg JJ, Shullo MA, Bezerra HG, Costa MA; et al. (2013). "Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study)". J Heart Lung Transplant. 32 (6): 596–602. doi:10.1016/j.healun.2013.02.005. PMID 23499356.

Template:WH Template:WS